151 related articles for article (PubMed ID: 30719802)
1. Is there a role for proton pump inhibitor prophylaxis in haematology patients?
Leitinger E; Hui L; Grigg A
Intern Med J; 2019 Jun; 49(6):694-701. PubMed ID: 30719802
[TBL] [Abstract][Full Text] [Related]
2. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
Soubra L; Issa M
Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
[TBL] [Abstract][Full Text] [Related]
3. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
[TBL] [Abstract][Full Text] [Related]
4. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.
Yachimski PS; Farrell EA; Hunt DP; Reid AE
Arch Intern Med; 2010 May; 170(9):779-83. PubMed ID: 20458085
[TBL] [Abstract][Full Text] [Related]
6. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
[TBL] [Abstract][Full Text] [Related]
7. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
Moriarty F; Bennett K; Cahir C; Fahey T
J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
[TBL] [Abstract][Full Text] [Related]
8. Prescribing of Proton Pump Inhibitors in an Irish General Practice.
O’Mahony L; Yelverton E
Ir Med J; 2019 May; 112(5):932. PubMed ID: 31411014
[TBL] [Abstract][Full Text] [Related]
9. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
[TBL] [Abstract][Full Text] [Related]
10. We have had a gutful: The need for deprescribing proton pump inhibitors.
Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
[TBL] [Abstract][Full Text] [Related]
11. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).
Blank ML; Parkin L
J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].
Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P
Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010
[TBL] [Abstract][Full Text] [Related]
13. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
Luo H; Fan Q; Xiao S; Chen K
BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drug prescriptions in hospital inpatients: are we assessing the risks?
Kitchen J; Kane D
Ir J Med Sci; 2010 Sep; 179(3):357-60. PubMed ID: 20512664
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
Craig DG; Thimappa R; Anand V; Sebastian S
QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
[TBL] [Abstract][Full Text] [Related]
16. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
Lenoir C; El Biali M; Luthy C; Grosgurin O; Desmeules JA; Rollason V
Int J Clin Pharm; 2019 Dec; 41(6):1634-1641. PubMed ID: 31664687
[TBL] [Abstract][Full Text] [Related]
17. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection-a cross-sectional population-based study.
Wallerstedt SM; Fastbom J; Linke J; Vitols S
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):9-16. PubMed ID: 27859947
[TBL] [Abstract][Full Text] [Related]
19. SHORT COMMUNICATION-Inappropriate use of proton pump inhibitor for stress ulcer prophylaxis in a tertiary care hospital in Karachi, Pakistan.
Samar R; Ali SA; Samar V; Mushtaq MZ; Humayun A
Pak J Pharm Sci; 2021 Nov; 34(6):2253-2255. PubMed ID: 35034888
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the initiation of proton pump inhibitors in corticosteroid users.
Munson JC; Wahl PM; Daniel G; Kimmel SE; Hennessy S
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):366-74. PubMed ID: 22278844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
